Hyperfine Announces Enrollment of First Patient in Study to Expand Intended Use of the Swoop(R) System with Contrast Agents

(Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain--the Swoop (R) system--today ...

ACA Pharma Named Exclusive Distributor for Ferabright™ in Macau, Hong Kong, Singapore, Greater Bay Area & Mainland China

ACA Pharma: [email protected] Azurity Pharmaceuticals: [email protected] ...
Medscape

Is Contrast-Free MRI the Optimal Test for PC?

A twist on magnetic resonance imaging that does not require gadolinium contrast appears to be as effective as standard imaging at detecting prostate cancers, according to a new study in JAMA. Experts ...
Kaleido Scope

What you should know about medical contrast imaging

Mason Frazier, M.D., associate professor in the University of Alabama at Birmingham’s Marnix E. Heersink School of Medicine’s Department of Radiology, says contrast imaging is important part of ...
Neurology Advisor

Medical Imaging Contrast Media Contribute to Environmental Pollution

Contrast media used for medical imaging may be contributing to environmental pollution as researchers measure and consider the impact.

ISMI Introduces a Radiologist-Led Full-Body MRI Program Focused on Diagnostic Clarity and Long-Term Health Planning

ISMI offers a radiologist-led Full-Body MRI in Montreal to identify life-saving findings, detect health risks, and support ...

Hyperfine Announces Enrollment of First Patient in Study to Expand Intended Use of the Swoop® System with Contrast Agents

Prospective study is designed to evaluate the feasibility and visualization benefits of contrast-enhanced ultra-low-field portable MRI.